Rosen Law Firm says it filed Alibaba securities class action, seeks lead plaintiff by Oct. 5, 2026

By Atlas Watchline Staff · Legal · August 4, 2026

Rosen Law Firm says it filed a securities class action against Alibaba Group Holding Limited and is seeking a lead plaintiff by Oct. 5, 2026.

Rosen Law Firm says it filed a securities class action lawsuit against Alibaba Group Holding Limited and is seeking a lead plaintiff by Oct. 5, 2026, in a notice published Aug. 4, 2026.

The notice says the case covers people who purchased Alibaba securities between June 26, 2025, and June 24, 2026, both dates inclusive. It says investors who bought during that period may be entitled to compensation without out-of-pocket fees or costs through a contingency fee arrangement.

According to the notice, the lawsuit alleges defendants made false and/or misleading statements and failed to disclose several points. Those include claims that entities directly or indirectly controlled by or affiliated with China’s MIIT were considered a Chinese military company under the National Defense Authorization Act, that Alibaba was directly or indirectly controlled by or affiliated with the MIIT, and that the risk of Alibaba carrying out distillation attacks against third-party AI models was ongoing rather than merely hypothetical or inadvertent.

The notice also says the alleged misstatements concerned Alibaba’s business, operations and prospects, and that those statements were materially false and misleading and/or lacked a reasonable basis. It says investors suffered damages when the true details entered the market.

The notice includes contact information for people who want to join the case or seek more information. It says investors who want to serve as lead plaintiff must move the court no later than Oct. 5, 2026.

No response from Alibaba was included in the notice provided for this report.

Sources

PR Newswire / Rosen Law Firm notice

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.

This is the AMP version of the article. Read the full article on Atlas Watchline.